ABOUT US
R&D
AGORA
PR
RECRUITMENT
CONTACT
Moonkyung Choe, Ph.D., CEO of 3H Bio Co., Ltd., Korea.
She received her Ph.D. degree from the College of Science and Convergence Technology, Hanyang University in Korea, and was trained as a researcher in Postech and Gachon University, Korea.
Hyung-Ji Kim, M.D., Ph.D., is Co-CEO of 3H Bio Co., Ltd., Korea, and concurrently works as an assistant professor at the Department of Neurology, Eulji University School of Medicine.
He received his Ph.D. degree from the College of Medicine, University of Ulsan, and has trained as a dementia specialist at Asan Medical Center, Seoul, Korea.
Hyo Joon Kim, Ph.D., CTO of 3H Bio Co., Ltd., Korea, is an Emeritus Professor at the Division of
Molecular and Life Science, Hanyang University.
He received his Ph.D. degree from the College of Pharmacy, Osaka University in Japan, and was trained as a Post Doc in the Center for Cancer Research at MIT, USA.
His scientific research on obesity immunotherapeutics has been supported by successive
grants from the Ministry of Sciences and Technology,
the Ministry of Knowledge and Economy,
and the Ministry of Education, Science and Technology of Korea.
Mr. Choi, Jae Kyoung is the co-founder of 3H Bio working as CFO.
He has been working as company builder and venture capital since 1997.
He has various experience in company building and
venture capital including from co-founding to being listed on stock market.
He was the co-founder of I-Venture Capital as CEO and managing director of investment in Actnerlab.
He got MBA degree from the University of Sydney and the University of Texas at Austin.
Bert Binas, Ph. D., CSO of 3H Bio Co., Ltd., Korea.
He has a professional background in lipid metabolism and stem cell biology.
He received his doctorate in Cellular Biochemistry at the Central Institute for Molecular Biology (Germany), and postdoctoral training at the Roslin Institute (U. K.) and the Max Delbrueck Center for Molecular Medicine (Germany).
He was then an Associate Professor at Texas A&M University (USA) and a - now retired - Full Professor at Hanyang University (Korea).
Min Jae Kim, Ph.D., CDO of 3H Bio Co., Ltd., Korea.
He received his Ph.D. degree from the College of Science and Convergence Technology,
Hanyang University in Korea, and was trained as Post Doc in the same place.
Munsik Seol has served as Auditor in 3H Bio Co., Ltd., since 2021.
He graduated Seoul National University with a bachelor's degree in Economics.
He had worked in finance and budget for more than 30 years in the Ministry of Finance, Budget Administration, Presidential Office, Ministry of Economy and Finance in Korea government.
He had worked as Vice Governor of economic affairs in Chungcheongbuk-Do Province from 2012 to 2017.
He also served as chairman of Board of Chungcheong University from 2021 to February 2023.
Henry M. Kaiser, Psy.D., MBA, has served as Executive Advisor in 3H Bio Co., Ltd.
He got an MBA degree from the Stanford University Graduate School of Business, and a Psy.D.
degree from Meridian University. He is Chairman Emeritus of Thomsen’s Inc.
He has served in numerous leadership roles on Portfolio Company Boards and community and arts organizations.
He previously served as President and sat on the Board of Directors of Kaiser Foundation International’s global health care consulting activity,
as a Director of the Kaiser Foundation Hospitals & Health Plan, and as a Trustee of Kaiser Family Foundation.